8 New IPOs scheduled for Week of May 5

Francis Gaskins  |

Complete IPO calendar at IPOpremium.com

In order of largest IPO first.

(1) Based in Parsippany, NJ, PBF Logistics ($PBFX) scheduled a $275 million IPO on the NYSE with a market capitalization of $636 million at a price range midpoint of $20 for Friday, May 9, 2014.

PBFX is a fee-based, growth-oriented, traditional Delaware master limited partnership recently formed by PBF Energy (PBF) to own or lease, operate, develop, and acquire crude oil and refined petroleum products terminals, pipelines, storage facilities, and similar logistics assets.

(2) Based in Gabian, Monaco, GasLog Partners LP ($GLOP) scheduled a $168 million IPO on the NYSE with a market capitalization of $196 million at a price range midpoint of $20 for Thursday, May 8, 2014.

GLOP is a growth-oriented limited partnership formed to own, operate, and acquire liquefied natural gas (LNG) carriers engaged in LNG transportation under long-term charters, which GLOP defines as charters of five full years or more.

(3) Based inBeijing, China, Cheetah Mobile ($CMCM) scheduled a $162 million IPO on the NYSE with a market capitalization of $1.86 billion at a price range midpoint of $13.50 for Thursday, May 8, 2014.

CMCM has a diversified suite of mission critical applications that optimizes internet and mobile system performance and provides real time protection against known and unknown security threats.

(4) Based in Leesburg, VA, K2M Group Holdings ($KTWO) scheduled a $150 million IPO on the Nasdaq with a market capitalization of $630 million at a price range midpoint of $17 for Thursday, May 8, 2014.

KTWO is a global medical device company focused on designing, developing, and commercializing innovative and proprietary minimally invasive complex spine technologies and techniques.

(5) Based in Bothell, WA, Alder BioPharmaceuticals ($ALDR) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $407 million at a price range midpoint of $14 for Thursday, May 8, 2014.

ALDR is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

(6) Based in New York, NY, Alcentra Capital Corporation ($ABDC) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $192 million at a price range midpoint of $15 for Friday, May 9, 2014.

ABDC is a newly formed specialty finance company focusing on lower level junk bonds,

(7) Based in Nanjing, China, Tuniu ($TOUR) scheduled a $80 million IPO on the Nasdaq with a market capitalization of $471 million at a price range midpoint of $10 for Friday, May 9, 2014.

TOUR is a leading online leisure travel company in China. Top line revenue grew 75% in 2013 vs 2012 to $322 million, but TOUR has shown losses the last three years.

(8) Based in Cambridge, MA, Radius Health (RDUS) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $389 million at a price range midpoint of $15 for Thursday, May 8, 2014.

RDUS is a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

RDUS is a re-tread which originally scheduled its IPO for November '13.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SHGXY Shenguan Holdings Group Ltd ADR 1.19 0.00 0.00 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

DirectView Holdings Inc

DirectView Holdings Inc designs and installs surveillance systems, digital video recording and services. The company through its subsidiaries operates within two divisions security and surveillance and video conferencing services.